The number of people with susceptibility test result for rifampicin in Cuba
Cuba: The number of people with susceptibility test result for rifampicin was 40.43 in 2021. ▼ Falling
Latest (2021)
40.43
Change on year
down 20.2%
World rank
124th
of 146 countries
All-time high
71.13
in 2018
All-time low
40.43
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Cuba, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Cuba recorded 40.43 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 20.2% on the previous year and down 34.6% over five years.
Cuba ranks 124th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Cuba, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 61.83 | — |
| 2018 | 71.13 | +15.0% |
| 2019 | 66.18 | -7.0% |
| 2020 | 50.67 | -23.4% |
| 2021 | 40.43 | -20.2% |
Cuba compared with similar countries
- Cuba's 40.43 is below the median for upper middle income countries, which is 92.7, 44% of the median. (45 countries reporting)
- Cuba's 40.43 is below the median for Latin America & Caribbean, which is 59.38, 68% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 66.38 | 61.83 | 71.13 | 3 |
| 2020s | 45.55 | 40.43 | 50.67 | 2 |
Countries ranked near Cuba
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.64 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2020)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Cuba?
- The number of people with susceptibility test result for rifampicin in Cuba was 40.43 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Cuba?
- The highest recorded value was 71.13 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Cuba?
- The lowest recorded value was 40.43 in 2021.
- How does Cuba rank for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 124th out of 146 countries with data for 2021.
- Where does this Cuba data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).